Lipid profile in people starting antiretroviral therapy with efavirenz or dolutegravir based regimens from a reference center in Brazil: a cohort study. (2022). Research, Society and Development, 11(5), e55811528662. https://doi.org/10.33448/rsd-v11i5.28662